Searched for
RACHES ELLA
Bharat Biotech bets on vaccines to fight drug resistance, eyes post-Covid growthHyderabad-based Bharat Biotech is developing novel vaccines to combat antimicrobial resistance (AMR), a significant global health threat. T...- Bharat Biotech invests Rs 600 cr to expand into cell, gene therapiesAs per Bharat Biotech, the facility will tackle scientific challenges such as targeted gene expression, immune system modulation, and long-...
- Bharat Biotech launches cell gene therapy facility, eyes product launch by 2028Bharat Biotech has invested $75 million in its first cell and gene therapy facility in Telangana, India, aiming to launch new therapies in ...
- Bharat Biotech’s Covaxin has 77.8% efficacy rate, presents no safety concerns: Lancet studyCovaxin “induces a robust antibody response" two weeks after two doses are given, it said. “Covaxin’s Phase 3 efficacy results have been pe...
- Bharat Biotech's partner seeks Covaxin nod in US for children between 2 and 18 yearsThe US-based firm has applied for the authorisation based on the basis of the results of phase 2 and 3 clinical trials conducted on 526 chi...
- Covaxin gets WHO nod for emergency use, move to ease travel for those who took made-in-India vaccineCovaxin was also reviewed by WHO's Strategic Advisory Group of Experts on Immunisation (SAGE), which recommended the use of the vaccine in ...
- Covaxin gets WHO approval for emergency use listingWHO's TAG is an independent advisory group that provides recommendations to the WHO on whether a Covid 19 vaccine can be listed for emergen...
- Bharat Biotech's Covaxin gets WHO okay for emergency useHyderabad-based Bharat Biotech, which has developed Covaxin, submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine'...
- Covaxin phase-3 trial data to be out soon, says top executiveMore than five months after the Indian government approved Covaxin, the Hyderabad-based company has yet to publish its phase-3 trial data.
- Bharat Biotech seeks nod for Covaxin in 60+ countriesThe countries that granted emergency use licences (EUL) include Mexico, Philippines, Iran, Paraguay, Guatemala, Nicaragua, Guyana, Venezuel...
- Paediatric trials of Covaxin may begin in June: Bharat Biotech officialThe efficacy of the jab can be improved upto 100 per cent protection by the COVID-19 appropriate behaviour and following other safety proto...
- Bharat Biotech set to begin paediatric trials of Covaxin from June“It will be a trial on children aged 2-18 years,” said Raches Ella, Bharat Bio’s head-business development and international advocacy, addr...
- Covaxin safe, may be superior to similar vaccines: LancetIndia’s first indigenous Covid-19 vaccine Covaxin, codenamed BBV152, is safe, immunogenic and has no serious adverse effects, medical journ...
- Controversy swirls around India’s homegrown Covid-19 vaccineFrom the U.S. to the Norway, vociferous debates over the efficacy and safety of Covid-19 vaccines have beset pharmaceutical giants like Pfi...
- Bharat Biotech's Krishna Ella is a scientist who avoids any shortcutsElla never takes shortcuts and scientists at his foundation do more research work than probably any other institution in the country, say p...
- Bharat Biotech in tie-up to develop a Covid vaccineBharat Biotech said on Friday that it has partnered with the University of Wisconsin Madison and US-based company FluGen to develop a vacci...
Load More
